Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.45 USD | +0.24% | -0.35% | +0.12% |
Business Summary
Number of employees: 162
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Gene Therapies
100.0
%
| 41 | 100.0 % | 250 | 100.0 % | +511.16% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 41 | 100.0 % | 250 | 100.0 % | +511.16% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Alfred Sandrock
CEO | Chief Executive Officer | 67 | 22-02-28 |
Robin Swartz
DFI | Director of Finance/CFO | 53 | 21-08-31 |
Michael Higgins
CHM | Chairman | 61 | 15-07-21 |
Todd Carter
CTO | Chief Tech/Sci/R&D Officer | 54 | 18-10-31 |
Glenn F. Pierce
BRD | Director/Board Member | 68 | 17-01-04 |
James Geraghty
BRD | Director/Board Member | 69 | 13-12-31 |
Beth Shafer
PRN | Corporate Officer/Principal | - | 23-08-06 |
Human Resources Officer | - | 20-09-13 | |
General Counsel | - | 23-07-09 | |
Trista Morrison
HRO | Human Resources Officer | - | 22-09-18 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
George Scangos
BRD | Director/Board Member | 76 | 23-05-08 |
James Geraghty
BRD | Director/Board Member | 69 | 13-12-31 |
Glenn F. Pierce
BRD | Director/Board Member | 68 | 17-01-04 |
Catherine Mackey
BRD | Director/Board Member | 68 | 22-08-14 |
Steven E. Hyman
BRD | Director/Board Member | 71 | 15-09-16 |
Alfred Sandrock
CEO | Chief Executive Officer | 67 | 22-02-28 |
Grace E. Colón
BRD | Director/Board Member | 57 | 22-12-31 |
Nancy J. Vitale
BRD | Director/Board Member | - | 20-09-14 |
Michael Higgins
CHM | Chairman | 61 | 15-07-21 |
Jude Onyia
BRD | Director/Board Member | 60 | 23-02-20 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 54,393,628 | 45,197,482 ( 83.09 %) | 0 | 83.09 % |
Company contact information
Voyager Therapeutics, Inc.
75 Hayden Avenue
02421, Lexington
+857 259 5340
http://www.voyagertherapeutics.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.12% | 459M | |
+41.79% | 50.93B | |
-0.56% | 42.12B | |
+49.62% | 42.05B | |
-7.20% | 29.18B | |
+12.59% | 26.02B | |
-21.51% | 18.9B | |
+6.92% | 13.21B | |
+24.91% | 12.17B | |
+29.60% | 12.16B |
- Stock Market
- Equities
- VYGR Stock
- Company Voyager Therapeutics, Inc.